COVID-19 Vaccines

Philadelphia’s health commissioner said the city risks another epidemic of preventable deaths if health care workers don’t get inoculated against the coronavirus.

After the FDA advisers give their recommendation, the agency itself will make an official decision on whether to authorize boosters.

On Thursday, Pfizer and BioNTech formally applied for emergency use of a lower dose for 5- to 11-year-olds. Here’s what to expect:

Now the FDA will have to decide if there’s enough evidence that the shots are safe and will work for younger children like they do for teens and adults.

Health care workers, and university faculty, staff, and students, must have at least one dose of the COVID-19 vaccine by Oct. 15. Here’s what else you need to know.

As the call for boosters intensifies, Camden County is not planning to use the college mega-site it used the first time around because students are in class.

The event is being held to get more Delawareans vaccinated. The rate is now 79% for all adults, but barely half of younger adults have gotten their first dose.

J&J said it filed a request with the FDA to authorize boosters for people 18 and older who previously received the company's one-shot vaccine.

Health experts advise patience, and caution against stressing boosters in lieu of vaccinating the unvaccinated.

A key White House adviser talked about the matter with the CEOs of American, Delta, and Southwest, according to people familiar with the situation.

The health team was at SEPTA’s Norristown Transportation Center, and Gov. Tom Wolf got a closer look.

Teachers will no longer be exempted from Delaware’s mandate for all state workers to get their COVID-19 vaccine or submit to weekly testing.

The categories have expanded beyond just people who are immunocompromised. WHYY’s Health Desk Help Desk offers some basic booster answers.

With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they’re confident there will be enough for every American who qualifies.

Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing COVID-19 booster shots to shore up Americans’ protection against the virus.